B Christopher Ehrlich

Affiliations

  • Interim Chairman And Ceo at Cero Therapeutics Holdings Inc. (CERO), 2024-10-03
  • Chief Executive Officer at Launch One Acquisition Corp. (LPAA), 2024-07-11
  • at Effector Therapeutics Inc. (EFTR), 2024-06-13
  • Director at Transcept Pharmaceuticals Inc (TSPT), 2013-04-11
  • Director at Biomimetic Therapeutics Inc. (BMTI), 2013-03-05
  • Large Shareholder at Tesaro Inc. (TSRO), 2012-07-06
  • Other at Trius Therapeutics Inc (TSRX), 2010-08-10
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
EFTR $0.57 346 Director 35,213 2022-10-04 Filing
EFTR $0.55 18,867 Director 34,867 2022-09-26 Filing
EFTR $4.30 1,000 Director 16,000 2022-02-18 Filing
EFTR $4.45 2,000 Director 15,000 2022-02-14 Filing
EFTR $4.75 1,000 Director 13,000 2022-02-09 Filing